Trial intelligence / Profile preview

Evening primrose oil vs vaginal misoprostol for cervical ripening before hysteroscopic myomectomy

IRCT20201028049169N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Nov 2020
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of evening primrose oil and misoprostol in Fibromyoma (LM) (2 arms), sponsored by Tehran University of Medical Sciences. Started Nov 2020; status: completed.

02

Drugs

evening primrose oilmisoprostol
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on IRCT20201028049169N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201028049169N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call